250 related articles for article (PubMed ID: 19738114)
1. Guideline for 5-alpha-reductase inhibitors in the prevention of prostate cancer is premature.
Frankel PH; Twardowski P
J Clin Oncol; 2009 Oct; 27(30):e164; author reply e165. PubMed ID: 19738114
[No Abstract] [Full Text] [Related]
2. Open to debate. The Motion: all men over the age of 50 should be encouraged to take a 5alpha-reductase inhibitor to prevent prostate cancer.
Koltz L; Clarke N
Eur Urol; 2008 May; 53(5):1079-83. PubMed ID: 18308462
[No Abstract] [Full Text] [Related]
3. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
Andriole G; Bostwick D; Civantos F; Epstein J; Lucia MS; McConnell J; Roehrborn CG
J Urol; 2005 Dec; 174(6):2098-104. PubMed ID: 16280736
[TBL] [Abstract][Full Text] [Related]
4. High-grade prostate cancer and the prostate cancer prevention trial.
Logothetis CJ; Schellhammer PF
Cancer Prev Res (Phila); 2008 Aug; 1(3):151-2. PubMed ID: 19138948
[No Abstract] [Full Text] [Related]
5. The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer.
Cha EK; Shariat SF
Eur Urol; 2011 Apr; 59(4):515-7. PubMed ID: 21277077
[No Abstract] [Full Text] [Related]
6. Prostate cancer: a serious disease suitable for prevention.
Fitzpatrick JM; Schulman C; Zlotta AR; Schröder FH
BJU Int; 2009 Apr; 103(7):864-70. PubMed ID: 19302133
[TBL] [Abstract][Full Text] [Related]
7. The Prostate Cancer Prevention Trial and the future of chemoprevention.
Thompson IM; Tangen CM; Lucia MS
BJU Int; 2008 Apr; 101(8):933-4. PubMed ID: 18353157
[No Abstract] [Full Text] [Related]
8. Prevention of prostate cancer with finasteride.
Burke HB
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
[No Abstract] [Full Text] [Related]
9. Prevention of prostate cancer with finasteride.
Lee SC; Ellis RJ
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562805
[No Abstract] [Full Text] [Related]
10. Finasteride for prevention of prostate cancer.
Med Lett Drugs Ther; 2008 Jun; 50(1289):49-50. PubMed ID: 18583946
[No Abstract] [Full Text] [Related]
11. Prevention of prostate cancer with finasteride.
Barzell WE
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562803
[No Abstract] [Full Text] [Related]
12. Implementation of the Prostate Cancer Prevention Trial (PCPT).
Goodman PJ; Tangen CM; Crowley JJ; Carlin SM; Ryan A; Coltman CA; Ford LG; Thompson IM
Control Clin Trials; 2004 Apr; 25(2):203-22. PubMed ID: 15020037
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of prostate cancer: lessons learned.
Thompson IM
BJU Int; 2007 Jul; 100 Suppl 2():15-7. PubMed ID: 17594351
[No Abstract] [Full Text] [Related]
14. Prevention of prostate cancer with finasteride.
Ross RK; Skinner E; Cote RJ
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
[No Abstract] [Full Text] [Related]
15. Proscar and propecia--a therapeutic perspective.
Palusinski R; Barud W
J Clin Endocrinol Metab; 2004 Dec; 89(12):6359. PubMed ID: 15579805
[No Abstract] [Full Text] [Related]
16. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
Reed AB; Parekh DJ
Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of prostatic adenoma patients with inhibitor of 5-alpha-reductase of type I and II avodart (dutasteride)].
Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
Urologiia; 2006; (6):83-6. PubMed ID: 17315721
[No Abstract] [Full Text] [Related]
18. New finasteride trial results aim to curb controversy.
Bankhead C
J Natl Cancer Inst; 2006 Aug; 98(16):1104-5. PubMed ID: 16912260
[No Abstract] [Full Text] [Related]
19. Prevention of prostate cancer with finasteride.
Rubin MA; Kantoff PW
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14561801
[No Abstract] [Full Text] [Related]
20. 5 alpha-reductase and finasteride in pattern alopecia and acne.
Burkhart CG; Burkhart CN
J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
